March 6 (SeeNews) - Croatian pharmaceuticals distributor Medika Group [ZSE:MDKA] said its consolidated net profit rose to 20.1 million euro ($ 21.9 million) last year from 15.5 million euro in 2022.
Medika's operating revenue reached 751.6 million euro from 628.9 million euro, it said in a consolidated unaudited report filed with the Zagreb bourse last week.
Operating costs grew to 728.2 million euro last year from 610.9 million euro in 2022.
Consolidated sales revenue went up to 745.8 million euro in 2023 from 624.3 million euro.
Medika’s shares were the biggest daily gainer on Wednesday morning on the Zagreb bourse as they traded 2.70% higher at 7,600 euro.
($ = 0.920 euro)